Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/135075
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients
Author: Friedman, D.J.
Qin, L.
Parzynski, C.
Heist, E.K.
Russo, A.M.
Ranasinghe, I.
Zeitler, E.P.
Minges, K.E.
Akar, J.G.
Freeman, J.V.
Curtis, J.P.
Al-Khatib, S.M.
Citation: Journal of the American College of Cardiology, 2022; 79(11):1050-1059
Publisher: ELSEVIER SCIENCE INC
Issue Date: 2022
ISSN: 0735-1097
1558-3597
Statement of
Responsibility: 
Daniel J. Friedman, MD, Li Qin, PHD, Craig Parzynski, MS E. Kevin Heist, MD, Andrea M. Russo, MD, Isuru Ranasinghe, MBCHB, MMED, PHD, Emily P. Zeitler, MD, MHS, Karl E. Minges, PHD, MPH, Joseph G. Akar, MD, PHD, James V. Freeman, MD, MPH, MS, Jeptha P. Curtis, MD, Sana M. Al-Khatib, MD, MHS.
Abstract: BACKGROUND The subcutaneous (S-) implantable cardioverter-defibrillator (ICD) is an alternative to the transvenous (TV-) ICD that is increasingly implanted in younger patients; data on the safety and effectiveness of the S-ICD in older patients are lacking. OBJECTIVES The purpose of this study was to compare outcomes among older patients who received an S- or TV-ICD. METHODS The authors compared S-ICD and single-chamber TV-ICD implants in Fee-For-Service Medicare beneficiaries using the National Cardiovascular Data Registry ICD Registry. Outcomes were ascertained from Medicare claims data. Cox regression or competing-risk models (with TV-ICD as reference) with overlap weights were used to compare death and nonfatal outcomes (device reoperation, device removal for infection, device reoperation without infection, and cardio- vascular admission), respectively. Recurrent all-cause readmissions were compared using Anderson-Gill models. RESULTS A total of 16,063 patients were studied (age 72.6 ± 5.9 years, 28.4% women, ejection fraction 28.3 8.9%). Compared with TV-ICD patients (n ¼ 15,072), S-ICD patients (n ¼ 991, 6.2% overall) were more often Black, younger, and dialysis dependent and less likely to have history of atrial fibrillation or flutter. In adjusted analyses, there were no differences between device type and risk of all-cause mortality (HR: 1.020; 95% CI: 0.819-1.270), device reoperation (subdistribution [s] HR: 0.976; 95% CI: 0.645-1.479), device removal for infection (sHR: 0.614; 95% CI: 0.138-2.736), device reoperation without infection (sHR: 0.975; 95% CI: 0.632-1.506), cardiovascular readmission (sHR: 1.087; 95% CI: 0.912-1.295), or recurrent all-cause readmission (HR: 1.072; 95% CI: 0.990-1.161). CONCLUSIONS In a large representative national cohort of older patients undergoing ICD implantation, risk of death, device reoperation, device removal for infection, device reoperation without infection, and cardiovascular and all-cause readmission were similar among S- and TV-ICD recipients.
Keywords: Humans
Death, Sudden, Cardiac
Treatment Outcome
Retrospective Studies
Defibrillators, Implantable
Aged
Medicare
United States
Female
Male
Arrhythmias, Cardiac
Rights: Copyright status unknown
DOI: 10.1016/j.jacc.2021.12.033
Published version: http://dx.doi.org/10.1016/j.jacc.2021.12.033
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.